chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dizziness; fever; numbness; This is a spontaneous report from a contactable consumer, the patient. A 24-years-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: Er8733) via an unspecified route of administration in the left arm on 29Mar2021 at 10:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: En6206) via an unspecified route of administration in the left arm on 04Mar2021 at 09:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was not reported if the patient was allergic to medications, food, or other products. The patient experienced fever, numbness, dizziness on 30Mar2021 at 06:15. The patient did not receive any treatment for events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.   Clinical outcome of fever, dizziness, numbness was unknown at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Red expanding area around injection dute spreading g from upper arm down towards elbow. Hot to the touch. Itchy and painful to young patient.  Attending  at walk in clinic gave  liquid ibuprofen and prescribed medicine.
Hospitalized for Guillain-Barre syndrome on Dec. 4, 2013, for 9 days. Treated with intravenous steroids. In nursing home (for rehab therapy) for 5 weeks. Currently doing home physical and occupational therapy.
Patient called on 11/15/2021 stating that she received her pneumonia vaccine on 11/8/21 and two days later received an infusion (I believe for her Guillian-Barre syndrome) then woke up and hasn't been able to walk since.
inactivated Polio vaccine in the multi-dose form for an older patient that missed when he was supposed to be vaccinated with no adverse event; Initial information received on 26-Aug-2022 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves Elderly and unknown gender patient who missed dose of IPV (VERO) [IPOL] when he was supposed to be vaccinated with no adverse event.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient supposed to be received a dose of suspect IPV (VERO) (dose, strength, formulation, lot number : unknown) via unknown route in unknown administration site as immunisation.  On an unknown date the patient developed a non-serious event "inactivated polio vaccine in the multi-dose form for an older patient that missed when he was supposed to be vaccinated with no adverse event (product dose omission issue)" (unknown latency).  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
pt states awaking between 1-3Am & felt dizzy;states nausea & abd pain;no diarrhea or vomiting; c/o dizziness entire day;
Patient reports pain in her left arm that is at a constant 4-5 out of 10 during day, and 8-9 out of 10 while sleeping that started since she received SC varicella vaccine on 12/22/2020. Seen by PCP on 1/20/2021 before presenting to workplace occupational health clinic for 2nd dose of varicella and 2nd booster of Hep B on 1/25/2021.
Initial misuse report received from a healthcare professional on 09 August 2013. It was reported that PENTACEL was administered to a 5 year old patient. No adverse event was reported. List of documents held by sender: none.
Patient received a covid vaccine on 03/05/2021.  Daughter reports there were no side effects  that night or the following days.  The next Saturday, March 13, 2021, the daughter was at her parents house checking up on them.   Her father was in the bathroom as she passed in the hall.   He came out of the bathroom and proceeded to the living room, she stated dad are you ok?  He said he couldn't breath.  Giving his history of COPD and being short of breath sometimes, she didn't think anything of it.   She proceeded to follow him to his chair and was checking his oxygen tank that he had been using with ambulation.   It still had some in the tank.  She raised her head to tell him he still had some in the tank and saw that he had started "agonal breathing".  Daughter is a nurse and knew he needed help.   She phone for an ambulance and with the help of her mother got patient to the floor and started CPR.   Paramedics arrived on scene, continued CPR and administered meds and also intubated, but were unsuccessful in their efforts.
Information has been received from a health professional concerning a 12 year old white female who on 28-DEC-2006 was vaccinated intramuscularly with the first dose of HPV vaccine (yeast) (lot# 653735/0688F). Concomitant therapy included varicella virus vaccine live (MSD) received on 08-DEC-2006 and Menactra vaccine received on 27-NOV-2006.  On approximately 26-JAN-2007 the patient experienced an extremely heavy menstrual cycle with more cramps than previous cycles, one episode of pain in the groin area and shortness of breath while at basketball practice.  At the time of this report it was unknown if the patient had recovered from these events.
Fainting--Gently laid patient onto ground and examined breathing. Once breathing confirmed to be normal, feet were elevated and the patient regained consciousness within 30 seconds. EMT arrived and examined the patient in which they found his vitals within normal range. At this time, they allowed the patient to leave on his own accord.
excursion max: 11.6 C for one hour; excursion max: 11.6 C for one hour; This is a spontaneous report. A contactable nurse reported for a consumer (patient) via Medical information team.This case was created for the 10th patient. A patient of unspecified age and gender received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13, Solution for injection in pre-filled syringe), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for immunization. The patient medical history and concomitant medications were not reported. On an unspecified date it was reported that seeks stability; excursion max: 11.6 C for one hour. non single excursion. Patients involved: 10 Paediatrics (Prevnar only). For product TRUMENBA no patient was involved. The outcome of the events was unknown.  No follow-up attempts are needed. information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021268716 same reporter/drug/event, different patient.
Received flu vaccine on 10/12/07 around 1:45pm. On 10/13/07 around 4 pm noticed back itching. The next morning 10/14/07 noticed "hives" under arms, on chest and uppr abdomen and itching of entire torso and groin. He went to the emergency room around 4pm because of intensity of symptoms and received a shot of prednisone and a prescription for oral prednisone.
SEVERE BODY PAIN; NERVE ISSUES; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the subject experienced severe body pain, and nerve issues. The action taken with covid-19 vaccine  was not applicable. The patient had not recovered from severe body pain, and nerve issues. This report was non-serious.
Reddened/edematous, 4in. diameter, warm in upper left arm. Given Claritin, use warm packs to arm.
started experience body aches, chills, nuasea, dry cough. temp  101.5 today. has not taken anything for the fever.
Respiratory arrest occurred approximately 5 hours post vax. In ICU. Survival doubtful.  A follow up report received 8/3/2000 adds: Call from MD - he has no further info on where pt was hospitalized or if he has recovered or not. MD has no more info about this pt.
On September of 2021 I started having persistent inflamed lymph nodes, I had them the first time on the left side of my neck. I got them checked out and they said it can be an infection but I was feeling completely fine, no signs of an infection. They disappeared after 2 months or so and now they're showing on the right side of my neck. I'm getting that checked again next week. Another issue I got is I was diagnosed with Alopecia Areata on December 2021. I have no family history with areata which makes me believe it was caused by the vaccine.
Systemic: Body Aches Generalized-Severe, Systemic: Fever-Medium, Systemic: Nausea-Medium, Additional Details: Patient describes also skin painful to touch along with pain all over her body. Describes pain as the worst she has ever had.
stored in the refrigerator for more than 30 days; administered with the vaccine which has been stored in the refrigerator for more than 30 days; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered with the vaccine which has been stored in the refrigerator for more than 30 days) and PRODUCT STORAGE ERROR (stored in the refrigerator for more than 30 days) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered with the vaccine which has been stored in the refrigerator for more than 30 days). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (stored in the refrigerator for more than 30 days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered with the vaccine which has been stored in the refrigerator for more than 30 days) and PRODUCT STORAGE ERROR (stored in the refrigerator for more than 30 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  Healthcare provider (HCP), an emergency medical technician, reported that they administered 2 lot numbers of the Moderna Covid-19 vaccine which had been stored in the refrigerator for more than 30 days to 18 patients. They said 2 lots - 039B21A, expiration date 02Oct2021 and 048B21A, expiration date 09Oct2021 - were placed in the refrigerator on 18Jun2021. HCP claimed that the vaccines did not experience temperature excursion while in the refrigerator. They wanted to seek guidance as to how to proceed in this situation e.g whether they should give an extra dose or not.  No treatment medications were provided.  Crosslinked with MOD21-122955, MOD21-122994, MOD21-122995, MOD21-122996, MOD21-122997, MOD21-122998, MOD21-122999, MOD21-123000, MOD21-123001, MOD21-123002, MOD21-123003, MOD21-123004, MOD21-123005, MOD21-123006, MOD21-123007, MOD21-123008 and MOD21-123009.   This case was linked to MOD-2021-265450 (Patient Link).
scratchy nose/sinus and sore throat; scratchy nose/sinus and sore throat; This is a spontaneous report from a Pfizer-. A contactable consumer (patient) reported that a female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via unspecified route of administration on an unknown date in Jan2021 (reported as first dose was 3 weeks ago), as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that she was scheduled to take the second dose of the COVID-19 vaccine today on 03Feb2021 and experiencing scratchy nose/sinus and sore throat on an unknown date in 2021 and she has been taking sinus medication for it. She wanted to know if she will take the second dose today. The outcome of the events was unknown.  The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Patient completed the oral typhoid vaccine on November 13, 2006.  (She started it on November 7th.)  She describes GI upset (nausea, diarrhea and stomach cramping) that started with taking the first pill and has gradually improved up until today's date.  She has also felt hot but has not had any temps over 99 degrees.  She also describes daily frontal headaches.
Tinnitus and high blood pressure starting 2 days after first injection and still happening 12 days after.  Second injection scheduled for April 13, 2021.
Vaccines given at 1250, pt tensed, gritted teeth immed. afterward & passed out onto exam table. Out x 45sec. Clammy, pale & pulse thready. BP initially 80/50. Observed child x 1 hr & did improve. Color more pink, BP 90/60. Could stand w/ help. DC'd to mom - took home. Dr. spoke with mom by phone approximately 3pm & child 100% better.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ACUTE NON ST ELEVATION MI  11/5/2022,  12/13/2022,  2/20/2023,  1/6/2023 -- RECURRENCE OF SAME SYMPTOMS
Awoke the day after smallpox and yellow fever with photophobia, myalgia, fever and "confusion". fever adn confusion resolved after "couple" hours, followed by paralysis (unable to speak, move arms, legs), this lasted "couple" hours. pt fell asleep.  awoke 20 feb with myalgia and photophobia. exam (including neuro) unremarkable. ophthalmology evaled pt and had no findings.  cbc nml. d/c'd from urgent care clinic.  Seen 21feb smiling, all sx's resolved except mild photophobia. will be evaled again later today by opthalmology.
Patient experienced syncope after the second vaccine (the shingrix) was adminstered and stated they were close to passing out. This was the patients first time receiving immunizations. The syncope lasted for approximately 5 minutes, the patient also vomited during this time. After the 5 minutes the patient stated they felt a lot better and were experiencing no further symptoms. The patient remained seated under supervision for about ten more minutes before they left the pharmacy.  The patient did not have any other symptoms during the immunization process.
can't shovel the snow and at night when he lays on his back, toss and turn due to the tightness; A lot of fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TIGHTNESS (can't shovel the snow and at night when he lays on his back, toss and turn due to the tightness) and FATIGUE (A lot of fatigue) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced MUSCLE TIGHTNESS (can't shovel the snow and at night when he lays on his back, toss and turn due to the tightness) and FATIGUE (A lot of fatigue). At the time of the report, MUSCLE TIGHTNESS (can't shovel the snow and at night when he lays on his back, toss and turn due to the tightness) and FATIGUE (A lot of fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported
area was hot; Patient had little discomfort on 1st day of receiving vaccine; her arm started itching at injection site 7 days after receiving 1st dose; she felt fatigued; it is still big and red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (area was hot), DISCOMFORT (Patient had little discomfort on 1st day of receiving vaccine), VACCINATION SITE PRURITUS (her arm started itching at injection site 7 days after receiving 1st dose), FATIGUE (she felt fatigued) and VACCINATION SITE ERYTHEMA (it is still big and red) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     Concomitant products included AMLODIPINE, ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) and HYDROCHLOROTHIAZIDE, VALSARTAN (DIOVAN HCT) for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced VACCINATION SITE WARMTH (area was hot), DISCOMFORT (Patient had little discomfort on 1st day of receiving vaccine), VACCINATION SITE PRURITUS (her arm started itching at injection site 7 days after receiving 1st dose), FATIGUE (she felt fatigued) and VACCINATION SITE ERYTHEMA (it is still big and red). The patient was treated with ACETAMINOPHEN for Adverse event, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (area was hot), DISCOMFORT (Patient had little discomfort on 1st day of receiving vaccine), VACCINATION SITE PRURITUS (her arm started itching at injection site 7 days after receiving 1st dose), FATIGUE (she felt fatigued) and VACCINATION SITE ERYTHEMA (it is still big and red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided by the reporter       Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Follow up received on 22-JUN-2021 contains significant information includes event update, Reporter's details, product information.
I developed Spontaneous chronic urticaria and Dermatographism. The dermatographia has subsided. But over six months later I am still having daily hives.
On 7/21/01, right arm where TD booster was given turned red and hot. Went to ER around 19:00 and doctor dx'd adverse reaction and Rx'd him with antibiotic.
Random sharp pains in abdomen (RLQ, RUQ, and occasionally in the area of the right ovary), prolonged pain in both calves. All other vaccine side effects have disappeared shortly after vaccination aside from these two.
Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. The patient at was inoculated with ZOSTAVAX, 1 DF, (lot# and route unknown) vaccine on or about 04-AUG-2015 at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 28-NOV-2016 the patient was treated by a physician for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster, or shingles. The patient has been prescribed VALTREX, calamine lotion, and hydrocortisone cream for management of his persistent and painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Information has been received from a physician concerning an elderly patient who on 21-MAY-2009, was vaccinated with VARIVAX (Merck) instead of ZOSTAVAX (Merck) due to a human error. No adverse effect reported. Additional information has been requested.
Every month since receiving the vaccine the pain from my period is unbearable. I am in extreme pain. I have never had this type of pain. I have an appointment with my doctor to see if it could be anything else. But the pain is only during my period.
Nurse preparing vaccine errrantly diluted vaccine vial with 0.22ml  of saline when 2.2ml of saline is required by manufacturer to dilute vaccine vial. Nurse gave 0.2ml dose of concentrated vaccine to patient. When realized error after vaccine already administered,patient had already gone home. Nurse  notified MD and Nurse Manger. Nurse manager notified parent of patient of concentrated dose adminsered in error. Parent reported patient was busy coloring and watching favorite movie and decline phone appointment with MD. Parent give MD instruction via Nurse Manager to observe for 24 hours for adverse affects and call if concerns/questions. Telephone appt made for next day for follow up if needed.
Asymptomatic positive COVID-19 result. Presented to ED for evaluation of back pain.
10 min after recieving vaccine: - increased HR - itchy over entire body - Benadryl given - ER for further eveluas
Pt recvd vax & w/in 4 hrs of the vax devel h/a, myalgias, fever of 103, chills, & assoc elevated liver function tests;
This spontaneous report as received from a Registered Nurse refers to multiple unspecified patients of unknown age and gender. On an unspecified date the multiple unspecified patients were administered COMVAX (Lot # unspecified) dose, frequency, route and location unspecified was stored improperly (first exposed to 9C for 30 minutes and then exposed to 8.3C for 1 hour). No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Pt. reports three days after vaccine she developed widespread muscle and joint aches. This pain was quite intense and did last for two weeks. Still has hip and feet discomfort which are gradually resolving.
Client was seen in ER. Leg leg swollen "2x normal size, hot, red, bump/ball under lower injection site." Limping with pain. Benadryl and antibiotics prescribed. Better by next morning.
Yesterday afternoon (which was exactly 1 week from receiving my first dose of the COVID-19 vaccine), I noticed my shoulder was strangely itchy and felt a bit bumpy. When I got home from work I examined it further and noticed it was a bit red, blotchy, warm, and raised in about a  3-4inch patch of skin around where  I received my injection.  This morning it looked the same and was even itchier. This afternoon it still feels warm and a bit tight/sore like when I first received the injection.  Naturally, I googled my symptoms  and came upon reports of 'covid arm', which were judged to be annoying but ultimately harmless which sounds a lot like what I'm experiencing, and as my mother reminded me, I've always had very sensitive skin! So I haven't done much to treat it except put a tshirt over it to make sure I leave it alone.